Journals / Turkish Journal of Gastroenterology / 2019 / Cilt: 30 - Sayı: 6

Validity and reliability of the Quality of Life in Reflux and Dyspepsia (QoLRAD) questionnaire in patients with gastroesophageal reflux disease for the Turkish population

Pages
511–516
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The lowest correlation (0.10) was between Emotional Distress and Role-emotional Limitations, and the highest (0.34) was between Energy and Vitality.Conclusion: The QoLRAD test measuring quality of life, except some subdomains in our study that we performed on patients diagnosedwith GERD, was found to be valid and reliable.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aims: Gastroesophageal reflux disease negatively affects quality of life.
📊
Key Findings & Data:The aim is to improve quality of life because ofhigh recurrence rate.
💡
Conclusion & Impact:The lowest correlation (0.10) was between Emotional Distress and Role-emotional Limitations, and the highest (0.34) was between Energy and Vitality.Conclusion: The QoLRAD test measuring quality of life, except some subdomains in our study that we performed on patients diagnosedwith GERD, was found to be valid and reliable.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background/Aims: Gastroesophageal reflux disease negatively affects quality of life. The aim is to improve quality of life because ofhigh recurrence rate. There is a strong need for patient-reported outcome measures. The present study aimed to evaluate the validityand reliability of the Quality of Life in Reflux and Dyspepsia Questionnaire (QoLRAD) to adopt it into Turkish.Materials and Methods: A total of 142 patients with complaints of heartburn or regurgitation once a week or commonly diagnosed with24-hour intraesophageal impedance-pH monitoring and/or upper gastrointestinal endoscopy were included in this study. Sociodemographic Data Collection Form, QoLRAD-TR, and Short Form-36 (SF-36) were applied to patients who were off proton pump inhibitors.Results: The Cronbach’s alpha coefficient value of the questionnaire was 0.97, and the intraclass correlation coefficient (ICC) valueof the result of test-retest method was between 0.97 (Vitality) and 0.99 (Eating/Drinking Disorders). There was a positive correlationbetween all subdomains of QoLRAD-TR and SF-36 scales. The lowest correlation (0.10) was between Emotional Distress and Role-emotional Limitations, and the highest (0.34) was between Energy and Vitality.Conclusion: The QoLRAD test measuring quality of life, except some subdomains in our study that we performed on patients diagnosedwith GERD, was found to be valid and reliable.

🔖

Cite This Article

HANÇERLİOĞLU, S., YILDIRIM, Y., BOR, S. (2019). Validity and reliability of the Quality of Life in Reflux and Dyspepsia (QoLRAD) questionnaire in patients with gastroesophageal reflux disease for the Turkish population. Turkish Journal of Gastroenterology, Cilt: 30 - Sayı: 6, 511–516. https://ajindex.com/articles/409279

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2005; 100: 190-200. [CrossRef] 2. Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 2013; 108: 308-28; quiz 329. [CrossRef] 3. Badillo R, Francis D. Diagnosis and treatment of gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther 2014; 5: 105-12. [CrossRef] 4. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastrooesophageal reflux disease: A systematic review. Gut 2005; 54: 710-7. [CrossRef] 5. Bor S, Sarıtaş Yüksel E. How is the gastroesophageal reflux disease prevalence, incidence, and frequency of complications (stricture/esophagitis/Barrett’s esophagus/carcinoma) in Turkey compared to other geographical regions globally? Turk J Gastroenterol 2017; 28(Suppl 1): S4-S9. [CrossRef] 6. Bor S, Kitapcioglu G, Elmas Kasap E. Prevalence of gastroesophageal reflux disease in a country with a high occurrence of Helicobacter pylori. World J Gastroenterol 2017; 23: 525-32. [CrossRef] 7. Kulich KR, Malfertheiner P, Madisch A, et al. Psychometric validation of the German translation of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QoLRAD) questionnaire in patients with reflux disease. Health Qual Life Outcomes 2003; 1: 62. [CrossRef] 8. Herregods TVK, Troelstra M, Weijenborg PW, Bredenoord AJ, Smout AJPM. Patients with refractory symptoms often do not have GERD. Neurogastroenterol Motil 2015; 27: 1267-73. [CrossRef] 9. Dent J. Long-term aims of treatment of reflux disease, and the role of non-drug measures. Digestion 1992; 51(suppl 1): 30-4. [CrossRef] 10. Dent J, Brun J, Fendrick AM, et Al. An evidence-based appraisal of reflux disease management - the Genval Workshop Report. Gut 1999; 44(Suppl 2): S1-S16. [CrossRef] 11. Wiklund IK, Junghard O, Grace E, et Al. Quality of life in reflux and dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QoLRAD). Eur J Surg 1998; 583: 41-9. [CrossRef] 12. Talley NJ, Fullerton S, Junghard O, Wiklund I. Quality of Life in Patients With EndoscopyNegative Heartburn: Reliability and Sensitivity of Disease-Specific Instruments Am J Gastroenterol 2001; 96: 1998-2004. [CrossRef] 13. Koçyiğit H, Aydemir Ö, Ölmez N, et al. SF-36’nın Türkçe için güvenilirliği ve geçerliliği. İlaç ve tedavi 1999; 12: 102-6. 14. Hinkle DE